Indications and uses
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat
adults and children 6 years and over 1 tablet daily; not more than 1 tablet in 24 hours children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor
do not use if printed foil under cap is broken or missing store between 20° to 25°C (68° to 77°F)
Loratadine 10 mg
Antihistamine
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
if you have ever had an allergic reaction to this product or any of its ingredients
liver or kidney disease. Your doctor should determine if you need a different dose.
do not take more than directed. Taking more than directed may cause drowsiness.
an allergic reaction to this product occurs. Seek medical help right away.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
adults and children 6 years and over | 1 tablet daily; not more than 1 tablet in 24 hours |
children under 6 years of age | ask a doctor |
consumers with liver or kidney disease | ask a doctor |
lactose monohydrate, magnesium stearate, povidone, pregelatinized starch
1-800-719-9260
Please reference the HOW SUPPLIED section listed above for a description of individual drug products listed below. This drug product has been received by Aphena Pharma Solutions - Tennessee, LLC in a manufacturer or distributor packaged configuration and repackaged in full compliance with all applicable cGMP regulations. The package configurations available from Aphena are listed below:
10mg
NDC 43353-259-60, Bottles of 90 Tablets
NDC 43353-259-18, Bottles of 3000 Tablets
NDC 43353-259-09, Bottles of 9000 Tablets
Store between 20°-25°C (68°-77°F). See USP Controlled Room Temperature. Dispense in a tight light-resistant container as defined by USP. Keep this and all drugs out of the reach of children.
Repackaged by:
Cookeville, TN 38506
20240409AMH
NDC 43353-259 - Loratadine 10 mg Tablets
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43353-259-09 | Loratadineantihistamine | 9000 in 1 BOTTLE | TABLET | 9000 | 5 | |
| 43353-259-18 | Loratadineantihistamine | 3000 in 1 BOTTLE | TABLET | 3000 | 5 | |
| 43353-259-60 | Loratadineantihistamine | 90 in 1 BOTTLE | TABLET | 90 | 5 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 43353-259-09 | EA - Each | 43353-259 | 4f48a585-f4e1-43eb-883a-b92a4d034b0e | 1 | 2022-11-07 |
| 43353-259-18 | EA - Each | 43353-259 | 950b5267-8d80-4f39-a5ec-ae2c3893e474 | 1 | 2022-12-07 |
| 43353-259-30 | EA - Each | 43353-259 | 6f202e78-a233-4da3-9f9d-6aa8b96c9cb3 | 1 | 2017-10-13 |
| 43353-259-60 | EA - Each | 43353-259 | 4ff1a088-61e6-42d8-8f18-2f07b179dd7a | 1 | 2023-09-05 |
| 45802-650-65 | EA - Each | 45802-650 | 2be54e45-0384-4ce9-95be-a3d9c2d051b9 | 1 | 2012-07-24 |
| 45802-650-78 | EA - Each | 45802-650 | 9595d39f-57b3-4c72-a349-5e7bf613881b | 1 | 2012-07-24 |
| 45802-650-87 | EA - Each | 45802-650 | a7cf4204-74e4-4e42-b2ff-961de1024e5e | 1 | 2012-07-24 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 43353-259 | 43353-259-60, 43353-259-18, 43353-259-09 |
| 45802-650 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| POVIDONE, UNSPECIFIED | FZ989GH94E | IACT |
| LORATADINE | 7AJO3BO7QN | ACTIB |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A076301-001 | LORATADINE | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A076301-001 | LORATADINE | 10MG | TABLET / ORAL | 2004-06-25 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Loratadine antihistamine | LORATADINE | Padagis Israel Pharmaceuticals Ltd | c72d8a30-520e-4d25-8f02-0c891e070a1a | 2025-09-12 | Warnings | 45802-650 |
| Loratadine antihistamine | LORATADINE | Aphena Pharma Solutions - Tennessee, LLC | a2c92766-df4e-4414-9c42-e18bcf9db6b4 | 2024-04-09 | Warnings | 43353-259-09 43353-259-60 43353-259-18 43353-259 43353025918 43353025909 43353025960 15aaaeb4-fda5-f5e2-e063-6394a90a47ee a2c92766-df4e-4414-9c42-e18bcf9db6b4 |
Adverse event summaries are temporarily unavailable. Other product information remains available.